CBF Cobra Bio-Man.

 

TIDMCBF 
 
RNS Number : 1694Y 
Cobra Bio-Manufacturing PLC 
28 August 2009 
 

+-------------------------------------+-------------------------------------+ 
| For Immediate Release               |                      28 August 2009 | 
+-------------------------------------+-------------------------------------+ 
 
 
Cobra Biomanufacturing Plc 
 
 
("Cobra" or "the Group" or "the Company") 
 
 
Trading Update 
 
 
Cobra Biomanufacturing Plc, the international provider of biopharmaceutical 
manufacturing services, gives the following update. 
 
 
Cobra has an order book of approximately GBP10 million. As previously reported, 
the capacity of the Group to continue as a going concern remains dependent on 
the Group delivering contract signatures and converting these contracts into 
revenue and cash receipts in line with expected timings. 
 
 
Trading conditions have resulted in a delay in the achievement of some contract 
signatures and Cobra continues to pursue alternative funding arrangements to 
meet the resulting working capital shortfall. 
 
 
Substantial progress has been made with a number of interested parties regarding 
potential interim and longer term financing and licensing arrangements. A 
further announcement will be made as appropriate. 
 
 
In addition, Cobra has completed a successful audit by the UK Medicines and 
Healthcare Products Regulatory Agency (MHRA) at its facility based at Keele. 
 
 
This authorisation is the result of a recent 3 day inspection and evaluation by 
the agency of Cobra's manufacturing, analytical and quality management systems 
and demonstrates that Cobra's facilities continue to meet international Good 
Manufacturing Practice (cGMP) standards. 
 
 
For further information, please contact: 
 
 
+--------------------------------------------------+---------------------------+ 
| Cobra Biomanufacturing Plc                       | Tel: +44 (0) 1782 714 181 | 
+--------------------------------------------------+---------------------------+ 
| Danny Chapchal, Interim Non Executive Chairman   |                           | 
+--------------------------------------------------+---------------------------+ 
| Simon Saxby, Chief Executive                     |                           | 
+--------------------------------------------------+---------------------------+ 
| Peter Coleman, Finance Director                  |                           | 
+--------------------------------------------------+---------------------------+ 
|                                                  |                           | 
+--------------------------------------------------+---------------------------+ 
| Buchanan Communications                          | Tel: +44 (0) 207 466 5000 | 
+--------------------------------------------------+---------------------------+ 
| Tim Anderson                                     |                           | 
+--------------------------------------------------+---------------------------+ 
| Rebecca Skye Dietrich                            |                           | 
+--------------------------------------------------+---------------------------+ 
|                                                  |                           | 
+--------------------------------------------------+---------------------------+ 
| Seymour Pierce (NOMAD & Broker)                  | Tel: +44 (0) 20 107 8000  | 
+--------------------------------------------------+---------------------------+ 
| Chris Howard                                     |                           | 
+--------------------------------------------------+---------------------------+ 
| Christopher Wren                                 |                           | 
+--------------------------------------------------+---------------------------+ 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 TSTSEASIASUSEIA 
 

Cobra Bio-manufacturing (LSE:CBF)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Cobra Bio-manufacturing (LSE:CBF)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024